Being in pain so intense that the only recourse is to hide in a dark, peaceful space till it is over several times a year would make anyone sad. Migraineurs, though, are five times most likely to develop depression than individuals who do not have these incapacitating headaches. Alternatively, people who are depressed are three times more likely than delighted individuals to become migraineurs.
Many researchers view the intertwining of migraine and depression as a chicken or egg circumstance. They are patently comorbid, but does one cause the other? Which one begins the depression, the migraine, or the process? The response is not that basic. Unsurprisingly, migraines, anxiety, and sleeping disorders, a state related to both conditions, have something typical. All three are associated with neurotransmitter shortages in the brain.
Doctors think that depression and migraine headaches have unique causes with comparative neurobiology while they are related. For years, medical professionals blamed depression in migraineurs on their resultant loss of quality of life due to headaches. However, the link is a shared biological mechanism instead of psychology.
One danger for scientifically depressed migraineurs is a possible drug interaction between their anxiety medication and migraine drugs. In July 2006, the FDA acknowledged one such danger: blending triptans for migraines with SSRIs (selective serotonin reuptake inhibitors) or SNRIs (serotonin and norepinephrine reuptake inhibitors) utilized to deal with depression and mood conditions. Combining the drugs can lead to a condition called serotonin syndrome.
Serotonin syndrome happens when there is too much serotonin in the body. Symptoms include hallucinations, increased heart rate, body temperature, fast changes in blood pressure, and intestinal upset. In some cases, a client has no choice but to take these medications together. However, they require to weigh their choices with their physician and keep track of carefully for serotonin syndrome.
Doctors believe that anxiety and migraine headaches have unique causes with similar neurobiology while they are related. Therefore, one risk for medically depressed migraineurs is a possible drug interaction between their depression medication and migraine drugs. In July 2006, the FDA acknowledged one such threat: blending triptans for migraines with SSRIs (selective serotonin reuptake inhibitors) or SNRIs (serotonin and norepinephrine reuptake inhibitors) used to deal with anxiety and mood conditions.